PUTTING IT ALL TOGETHER: Practical Approach Knee OA Patients Interested in Regenerative Medicine Jay Smith, MD Professor & Vice-Chair of of PM&R Departments.

Slides:



Advertisements
Similar presentations
Screening test of Pregnancy
Advertisements

ETHICS AND LAW Guidelines for treating people suffering from A.D. Ruth Goldberg.
Hip and Arthritis: Treatment Alternatives To Remain Active
1 OA Action Alliance Physical Activity Workgroup July 7, 2011.
Medication Therapy Management The Patient and Provider Variables.
CT & MRI – What is Expected from the Radiological Technologists Dr. Harsha Dissanayake MBBS, M.Phil, MD(Radiology) Dip. Neurovascular Diseases (France)
Ask Me Anything American Nurses Training Association.
Orthopaedics for the Practicing Internist
Self-Regulation in Chronic Disease Noreen M. Clark, Ph.D. March 23, 2002.
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Working with Databases.
What is REGENERATIVE MEDICINE? “The regeneration or replacement of cells, tissues or organs to restore or establish normal function.” The goal is to.
The End of the Disease Era Gero 302 Jan The Problem We now need to abandon disease as the focus for medical care. Clinical decisions should be made.
Cancer Program Standards 2012: Ensuring Patient-Centered Care
Optimal Pain Management for ED Patients: Issues in 2004 Edward P. Sloan, MD, MPH, FACEP Professor Department of Emergency Medicine University of Illinois.
Measuring Signs and Symptoms in Rheumatoid Arthritis David R. Karp, MD, PhD Chief, Rheumatic Diseases UT Southwestern Medical Center David R. Karp, MD,
DOCUMENTATION GUIDELINES FOR E/M SERVICES
Justin Coffey, MD Behavioral Health Services Terri Robertson, PhD Center for Clinical Care Design Perfect Depression Care.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 16: Economic Evaluation using Decision.
Amniotic Tissue. RMG Amniotic Injectable Live cellular product cryopreserved to maintain viability and potency Anti-inflammatory and Anti-microbial actions.
A Red Scaly Rash Small Group Teaching Problem Based Learning Dermatology Department College of Medicine King Saud University.
Guidelines for Prescribing
Part III Amy L. McIntosh, MD Pediatric Orthopedic Surgeon Mayo Clinic Rochester, Minnesota.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Copyright © 2015 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 6 Clinical Use of the Electronic Health Record.
Regulation of Promotion of Prescription Drugs Thomas W. Abrams, R.Ph., MBA Division of Drug Marketing, Advertising, and Communications Food and Drug Administration.
Background to Adaptive Design Nigel Stallard Professor of Medical Statistics Director of Health Sciences Research Institute Warwick Medical School
Case #13 Ellen Marie de los Reyes March 15, 2007.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Collegiate Wrestler with Bilateral Hip Bone Spurs: A Case Report Kan Sugiyama, Dr. Pamela Hansen, Dr. Jay Albrecht, Dr. Donna Terbizan North Dakota State.
Anemia Brad Conner and Sheree Rodeffer. Why should I care? Most common blood disorder in the US –Affects 4 million It can affect anyone –Women and individuals.
Photo: Trym I. Bergsmo. Best and worst cases Sameline Grimsgaard MD MPH PhD National research center in complementary and alternative medicine; NAFKAM.
Introduction: Medical Psychology and Border Areas
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Orlistat 60 mg Joint Meeting Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committees January 23, 2006 Andrea Leonard-Segal, M.D.
C-BR- 1 Raptiva ™ (efalizumab) Benefit:Risk Assessment Charles Johnson, MB, ChB Senior Director Head of Specialty Biotherapeutics Genentech, Inc.
KEN MAUTNER, MD EMORY SPORTS MEDICINE Clincal Application of PRP and Stem Cells in Knee Osteoarthrits.
Working with Orthopedic Surgeons Daniel Herman MD, PhD, CAQSM Asst. Professor, UF Department of Orthopaedics and Rehabilitation UF Running Medicine Clinic.
Nursing Process: The Foundation for Safe and Effective Care Chapter 5.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Evidence Based Medicine. What is Evidence Based Medicine? What qualifies as Evidence Based Medicine? Does Airrosti treat patients by utilizing an Evidence.
Prostate Cancer Management: A Guide for Patients and Caregivers
Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists
PO :Physical Therapy Administration. Learning Objectives The physical therapy technician will participate as a member of the physical therapy administration.
Sports Medicine in Orthopedics vs PM&R How Your Practice Might Differ
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Single Competency Framework for Prescribers National Prescribing Centre (2012)
Common Problems in the Emergency Department Intern Survival Kit 2013 The Northern Hospital Dr. Phyllis Fu Emergency Physician.
EVALUATION OF THE PAINFULL SHOULDER NICK KILMER, MD Primary Care Sports Medicine, University of Rochester RRFMC, OCTOBER 1, 2011 For unabridged PowerPoint,
Welcome to Asian Institute of Medical Sciences
OSTEOARTHRITIS OF THE KNEE DR. IRA GELB, POTOMAC VALLEY ORTHOPEDICS Kiran Pant, Intern/Mentor Program Mount Hebron High School.
Ten Minute Training March 21, 2012 Alerting. 2 |2 | DynaMed is an evidence-based clinical reference tool designed primarily for use by health care professionals.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Developing and Implementing Intervention Studies Using Geriatric Assessment Supriya Gupta Mohile, M.D., M.S. Assistant Professor of Medicine James Wilmot.
Efficacy of Colchicine When Added to Traditional Anti- Inflammatory Therapy in the Treatment of Pericarditis Efficacy of Colchicine When Added to Traditional.
Managing Patient-Centered Care. Outcomes Look at patient-centered care and the impact on health care delivery systems. Analyze the implications of are.
Hip & Knee OA: 5 Pearls to Delay the Dreaded Total Joint Replacement
OSTEOARTHRITIS DEGENERATIVE JOINT DISEASE
Evidence-based Medicine
Jennifer Koay, MD Assistant Professor Department of Radiology
THE APP THAT ALLOWS EVERY DOCTOR TO PRACTICE:
Multimorbidity: prevention and management
Gynaecological referrals from primary to secondary care Dr Fozia Malik MRCOG,DFSRH 14/11/2018.
Highgate Private Hospital Precision Hip & Knee
Non-Pharmacological Therapies, Chronic Pain and Opioid Addictions
Concepts of Nursing NUR 212
Chapter 2 Nursing Process
The Research Question Lateral epicondylosis (tennis elbow) is common, debilitating and often refractory to routine care. Prolotherapy, an injection-based.
Brian L. Lohrbach, MD Board-Certified Orthopedic Surgeon
Presentation transcript:

PUTTING IT ALL TOGETHER: Practical Approach Knee OA Patients Interested in Regenerative Medicine Jay Smith, MD Professor & Vice-Chair of of PM&R Departments of PM&R, Radiology & Anatomy Mayo Clinic, Rochester, MN AAPM&R 2015

REGEN MED CONSULT Disclosures Off-label use Off-label use PRP, BMC PRP, BMC Speaking honorarium Speaking honorarium Gulf Coast Ultrasound Institute Gulf Coast Ultrasound Institute Stock/Royalties – TENEX Health Stock/Royalties – TENEX Health Stock/CMO – Sonex Health Stock/CMO – Sonex Health

REGEN MED CONSULT Learning Objectives Discuss approach to patient with knee OA interested in regenerative medicine options Discuss approach to patient with knee OA interested in regenerative medicine options Practical Practical Patient encounter Patient encounter Best available science Best available science Level V evidence Level V evidence Focus on PRP & BMC Focus on PRP & BMC Prolotherapy Prolotherapy Structural fat grafts Structural fat grafts Other Other AMSCs – Mayo

REGEN MED CONSULT Clinical Presentation 60 y Male with left knee OA 60 y Male with left knee OA ‘’Can those stem cells cure my arthritis?” ‘’Can those stem cells cure my arthritis?” “Dr. X said you can regrow my cartilage.” “Dr. X said you can regrow my cartilage.”

REGEN MED CONSULT Be a Good Doctor  Perform a comprehensive physiatric evaluation Confirm diagnosis Confirm diagnosis Ensure reasonable prior Rx Ensure reasonable prior Rx Standard of care Standard of care Identify co-morbidities Identify co-morbidities Influence regen med options Influence regen med options Modify expected outcomes Modify expected outcomes Determine functional limitations & patient goals Determine functional limitations & patient goals “What do you want to achieve?” “What do you want to achieve?”

REGEN MED CONSULT History: Sx Profile & Past Eval Presenting symptoms Presenting symptoms Functional consequences Functional consequences Prior evaluation Prior evaluation Prior imaging Prior imaging Standing X-rays < 1 yr Standing X-rays < 1 yr Alignment Alignment MRI? MRI? Bone marrow lesions Bone marrow lesions Meniscal extrusion Meniscal extrusion

REGEN MED CONSULT History: Assess Prior Treatments Activity modification Activity modification Weight loss Weight loss PT/Exercise PT/Exercise Strength Strength Aerobics Aerobics Other Other Bracing/Wedges Bracing/Wedges Modalities Modalities PEMF, TENS, etc. PEMF, TENS, etc. Meds Meds Oral Topical Supplements Supplements Injections Injections Cortisone Hyaluronic acid Regen Surgery Surgery Underline – AAOS Guidelines Underline – AAOS Guidelines

REGEN MED CONSULT History: Prior Treatments – Why? Identify and discuss gaps in prior treatments Identify and discuss gaps in prior treatments Reinforce importance of holistic approach Reinforce importance of holistic approach (Re)-implement prior to regen med (Re)-implement prior to regen med Integrate into regen med Rx plan Integrate into regen med Rx plan Assess patient’s dedication Assess patient’s dedication Identify prior adverse reactions Identify prior adverse reactions Needle/procedure-phobic Needle/procedure-phobic Reaction to prior regen Rx Reaction to prior regen Rx

REGEN MED CONSULT History: Importance of Medical Hx May benefit from “medical tune-up” first May benefit from “medical tune-up” first Metabolic syndrome = pro-inflammatory Metabolic syndrome = pro-inflammatory Disclose limited knowledge & experience Disclose limited knowledge & experience Safety of PRP & BMC reasonably established Safety of PRP & BMC reasonably established Systemic inflammatory/autoimmune D/O’s? Systemic inflammatory/autoimmune D/O’s? Chronic infections (e.g. HIV, Hepatitis)? Chronic infections (e.g. HIV, Hepatitis)? Hematological (incl. marrow) disorders? Hematological (incl. marrow) disorders? History of cancer? History of cancer?  Honest discussion & documentation  Discuss/obtain permission from caregivers

REGEN MED CONSULT History: Medications/Supplements PRP PRP Avoid NSAIDs 1-2 weeks before (?after?) Avoid NSAIDs 1-2 weeks before (?after?) Others? Others? BMC (BMSCs) BMC (BMSCs) Immunosuppressives Immunosuppressives Statins Statins Others? Others?  Recommend common sense approach  Consider risks-benefits of medication changes

REGEN MED CONSULT History: Final Considerations Document date of last physical examination Document date of last physical examination < 1 year < 1 year Screening tests Screening tests Lab tests Lab tests Communicate with caregiver Communicate with caregiver “Permission” “Permission” Medication modifications Medication modifications Further evaluations Further evaluations

REGEN MED CONSULT Physical Examination Knee Knee Gait Gait Alignment Alignment Motion loss Motion loss Instability Instability Mechanical Sxs Mechanical Sxs Hip/Spine/Neuro Hip/Spine/Neuro Be sure it is a regen med treatable knee problem Be sure it is a regen med treatable knee problem Tendinosis, CPPD/gout, saphenous neuritis Tendinosis, CPPD/gout, saphenous neuritis

REGEN MED CONSULT Imaging Standing radiographs Standing radiographs K-L staging K-L staging Alignment Alignment MRI MRI Bone marrow lesions Bone marrow lesions May be painful May be painful Recognized & treated? Recognized & treated? Osteonecrosis Osteonecrosis Meniscal extrusion? Meniscal extrusion? Choi Eur J Orthop Surg Traum 2014

REGEN MED CONSULT Discussion & Treatment Options  Discuss diagnosis & Rx options Review “standard of care” Rx options Review “standard of care” Rx options Context of prior Rx Context of prior Rx Do nothing  surgery Do nothing  surgery Review regen med Rx options Review regen med Rx options Off-label, non-reimbursed Off-label, non-reimbursed Discuss patient specific options: Discuss patient specific options: Evaluation Evaluation Patient preferences Patient preferences Patient goals Patient goals

REGEN MED CONSULT Rx Options: Standard of Care Consider “standard of care” options Consider “standard of care” options Lateral wedge/brace Lateral wedge/brace Trial of crutches (e.g. BML) Trial of crutches (e.g. BML) “Need quick fix” – cortisone “Need quick fix” – cortisone Preparation for later regen Rx Preparation for later regen Rx Surgery may be best option Surgery may be best option

REGEN MED CONSULT Rx Options: PRP Discuss rationale, preparation & delivery Discuss rationale, preparation & delivery Multiple studies, including RCTs Multiple studies, including RCTs Reasonably safe Reasonably safe Physiologic > Regenerative Physiologic > Regenerative Slower onset vs. cortisone Slower onset vs. cortisone 40-60% improvement X 6-12 mos % improvement X 6-12 mos. May be better in K-L 1-2 May be better in K-L 1-2 Can be repeated (long term safety?) Can be repeated (long term safety?)

REGEN MED CONSULT Rx Options: BMC Discuss rationale, preparation & delivery Discuss rationale, preparation & delivery CE vs. BMC/BM-MNCs CE vs. BMC/BM-MNCs Details regarding BMA Details regarding BMA Few studies, no RCTs Few studies, no RCTs Reasonably safe Reasonably safe Mechanism of action? Mechanism of action? Potential disease modification Potential disease modification Expanded vs. BMC/BM-MNCs Expanded vs. BMC/BM-MNCs

REGEN MED CONSULT Rx Options: BMC 50% chance of > 50% improvement 50% chance of > 50% improvement 50-60% improvement (wide variability) 50-60% improvement (wide variability) Not all respond Not all respond May be slow onset (> 3 months) May be slow onset (> 3 months) Max improvement 3-6 months Max improvement 3-6 months Durability?, but hope > 12 months Durability?, but hope > 12 months Can be repeated, long term safety? Can be repeated, long term safety? More effective in K-L 3-4 vs. PRP? More effective in K-L 3-4 vs. PRP?

REGEN MED CONSULT Decision-Making & Documentation Discuss off-label use of PRP and BMC Discuss off-label use of PRP and BMC Discuss FDA positions (e.g. SVF) Discuss FDA positions (e.g. SVF) Discuss non-coverage by third party payors Discuss non-coverage by third party payors ABNs/Waivers ABNs/Waivers Set realistic expectations Set realistic expectations Be honest Be honest Under-promise & over-deliver Under-promise & over-deliver “At worst it’s a waste of time and money” “At worst it’s a waste of time and money” Document Document

REGEN MED CONSULT THANK YOU Questions & Discussion